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"ABSTRACT"
THE EFFECT OF HIGH INTENSITY EXERCISE TRAINING VERSUS LOW 
INTENSITY EXERCISE TRAINING ON FRACTIONATED PLASMA 
HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
By
Teresa L. Spate
Exercise training is thought to result in an elevation of high- 
density lipoprotein (HDL) and the cardioprotective subtraction 
HDL2 . Twenty-five healthy women (39 + 7.8 yrs; 70 14 kg) walked
two miles three times per week for 12 weeks to examine the effect 
of exercise intensity on the HDL profile. The L.I. group (N=12) 
walked at 60% of the heart rate reserve (HRR) and the H.I. group 
(N=13) walked at 80% HRR both maintaining the prescribed distance 
and frequency. A 22% increase in total HDL (from 32 6 to 39 8
mg/dl) and a 35% increase in HDL2 (from 14 3 to 19 ^ 9 mg/dl) was
elicited as a result of the walking program (p<.005). Slight 
increases in HDL3 were also observed. However, no significant 
differences in total HDL or HDL2 were observed between the L.I. and 
H.I. groups. These findings demonstrate an exercise induced 
enhancement of the cardioprotective mechanism thought to be 
associated with the HDL2 subtraction. Moreover, it appears that 
walking at 80% of the HRR offers no advantage over walking at 60% 
of the HRR in enhancing the HDL profile.
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CHAPTER ONE 
INTRODUCTION
Over 6 million Americans have a history of myocardial 
infarction, angina pectoris, or both. Coronary heart disease 
(CHD) claimed the lives of 478,530 Americans in 1991 and is the 
leading cause of death in the United States. This year as many 
as 1,500,000 Americans will have a heart attack, and about one 
third of them will die. Coronary heart disease will cost the 
American economy an estimated 56.3 billion dollars in 1994. (1) 
Although these numbers have been decreasing due to improved 
diagnostic and interventional technology, these data underscore 
the need for continued research in the areas of cardiovascular 
risk factors and prevention.
Risk factors for coronary heart disease can be divided into 
modifiable and non-modifiable categories. The modifiable risk 
factors include hypertension, cigarette smoking, physical 
inactivity and elevated total cholesterol. The non-modifiable 
risk factors include age, gender and family history of coronary 
heart disease.
Elevated total cholesterol level, as a risk factor, has
received much attention in the current literature. However, it
has been well documented that one's total cholesterol level does
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not adequately define an individual's risk for coronary heart 
disease (12,25). Total cholesterol is comprised of 3 major 
components: very low-density lipoproteins (VLDL), low-density 
lipoproteins (LDL) and high density lipoproteins (HDL). Each 
component must be studied separately to understand its 
independent contribution to the risk profile for coronary heart 
disease.
It has been documented that serum HDL cholesterol levels 
have a strong inverse relationship to the risk of coronary heart 
disease (2,12). The higher the HDL level, the lower the coronary 
risk. High levels of serum LDL cholesterol have been shown to 
have a direct relationship to the risk of coronary heart disease.
Plasma HDL concentration has been suggested to be a better 
predictor of coronary heart disease than total cholesterol 
levels. Each 10 milligram per deciliter (mg/dl) change in HDL 
cholesterol concentration is associated with a 50 percent 
alteration in cardiovascular risk (29). Other studies (10,12) 
have found a 1 mg/dl increment in HDL was associated with a 3.2 - 
3.9% decrement in CHD incidence. Thus, even small increases in 
HDL may result in a large reduction in the risk for coronary 
heart disease.
The HDL profile is comprised of subfractions HDL2 and HDL3 . 
The antiatherogenic properties of HDL appear to be specific to 
the subfraction HDL2 (3,25,26,30). Although total HDL levels may 
be increased by factors other than physical activity, increases 
in HDL2 have been found to occur primarily with exercise training
(25,30). The intensity of training required to elicit 
significant increases in HDL2 has not been established.
Purpose
The purpose of this study was to determine the effect of 
exercise intensity on the HDL profile.
CHAPTER TWO 
REVIEW OF LITERATURE
For several decades, evidence has been accumulating to 
indicate a causal relationship between elevated plasma 
cholesterol levels and coronary atherosclerosis (2) . Recent 
studies have indicated that total plasma cholesterol levels may 
be more predictive of coronary heart disease when the components 
are analyzed separately (4,16,25).
Cholesterol is an essential structural component of biologic 
membranes. Humans derive cholesterol endogenously, from 
synthesis in the liver and other tissues, and exogenously, from 
the consumption of animal products (7). A complex system 
delivers cholesterol and fatty acids to peripheral tissues, 
including the intimai lining of arterial walls, causing the 
formation of fatty streaks and eventually the atherosclerotic 
lesions characteristic of coronary heart disease. A separate 
system, known as reverse cholesterol transport, is thought to be 
responsible for returning cholesterol to the liver where it is 
converted to bile acids and excreted.
Total cholesterol comprises several major lipoprotein
classes, including very low-density (VLDL), low-density (LDL) and 
high-density (HDL) lipoproteins. The classes of lipoprotein 
differ not only in structure, but also in metabolism and, most 
importantly, in function (6 ). Evidence suggests that HDL, LDL, 
and VLDL lipoproteins, and their subfractions have different 
relationships to coronary heart disease risk (8 ). Epidemiologic 
studies demonstrate that a reduction in total plasma cholesterol 
or in LDL, and/or an elevation in HDL, results in decreases in 
the development of angina, positive exercise test results, and 
referral for coronary artery bypass surgery. Reductions in more 
severe cardiovascular end points such as heart attack, death, and 
atherosclerotic plaque progression also accompany these 
alterations in lipid profile. (2 )
Low-density lipoprotein is the major carrier of cholesterol 
in the blood stream, transporting 60-80 percent of the total 
plasma cholesterol (2). LDL levels have been shown to be 
directly related to the risk of coronary heart disease. The 
American Heart Association recommends a plasma LDL level of less 
than 130 mg/dl (32).
High-density lipoprotein is thought to be the carrier of 
cholesterol in the reverse cholesterol transport system. Among 
the various lipid subfractions, plasma HDL concentrations have 
been shown to be the strongest predictor of both the presence and 
extent of coronary heart disease (4,16). High-density 
lipoprotein has been shown to have a strong, inverse relationship 
with risk of coronary heart disease in numerous studies including
the Honolulu Heart Study (11), Framingham Study (12), Coronary 
Primary Prevention Trial (14) and the Helsinki Heart Study (15). 
The National Cholesterol Education Program (NCEP) states that an 
HDL level of 60 mg/dl or greater is a negative risk factor for 
CHD (27) . Data from the Helsinki Heart Study suggest that HDL- 
increasing therapies are associated with a decrease in incidence 
of coronary heart disease.
There are a few studies, however, that have failed to make 
the same associations. Results of angiographic studies range 
from HDL having a significant inverse relationship to the risk of 
coronary heart disease to HDL having no association at all (4). 
These findings may be, in part, the result of failing to analyze 
total high-density lipoprotein by its subfractions.
Total HDL is comprised of two groups with different 
biochemical properties, the more lipid-rich HDL2 and the smaller, 
denser HDL3 . Data from Drexel et al demonstrate that, among all 
lipoprotein parameters, HDL2 cholesterol is the strongest 
predictor of both the presence and extent of coronary heart 
disease (4). Patients with angiographically documented coronary 
heart disease had HDL2 levels nearly half that of individuals 
without coronary heart disease. Salonen et al (5) reported that 
an HDL level of less than 42 mg/dl is associated with a 3.32-fold 
increase in risk of acute myocardial infarction. Serum HDL2 
cholesterol levels of less than 25 mg/dl is associated with a 
4.00-fold increase in risk of acute myocardial infarction and 
serum HDL3 cholesterol levels of less than 15 mg/dl is associated
with a 2.04-fold increase in risk. In the same study the 
investigators confirmed that the HDL2 subfraction had an inverse 
association with the risk of acute myocardial infarction whereas 
the role of HDL3 remained equivocal. The association of HDL3 
with acute myocardial infarction lost its statistical 
significance when adjustment was made for HDL2 .
Environmental factors affecting the HDL profile are many. 
Factors including age, gender, physical activity, certain 
medications, cigarette smoking, consumption of alcohol, and 
obesity appear to influence HDL concentrations (19). Dietary 
intake has not been found to have a significant relationship to 
plasma HDL levels (17,19). A negative association has been found 
between HDL, the use of progestin preparations (18), beta- 
adrenergic antagonists (20,21), and cigarette smoking (13,17,18). 
A positive association has been found between HDL levels and age 
(25), regular physical activity (17), the use of estrogen 
preparations (18), alcohol consumption (17,19,25) and lean body 
mass (22) . HDL levels have also been shown to be higher in women 
than in men (23).
The difficulty in identifying the independent impact these 
factors may have on the development of coronary heart disease may 
be due to the fact that many of these lifestyle-related risk 
factors are often observed in conjunction with each other. This 
can easily be demonstrated by looking at individuals who smoke 
cigarettes. Cigarette smokers have been reported to be less 
obese and more likely to drink alcohol, both of which are
associated with higher levels of HDL cholesterol. Smokers may 
also exercise less, which has been associated with lower levels 
of HDL cholesterol (18).
Although many studies have associated environmental risk 
factors with either increased or decreased levels of HDL, few 
studies have examined the impact these factors have on the 
subfractions of HDL.
Robinson et al studied the effect a variety of risk factors 
had on total HDL, HDL2 , and HDL3 . Results of this study 
indicated that there is a positive association between age and 
HDL2 whereas there is no correlation to HDL3 (25) . The same 
study confirmed earlier findings of Haffner et al. that although 
the HDL profile is negatively associated with cigarette smoking 
and positively associated with alcohol consumption, the effects 
are a result of alterations in HDL3 levels (13). HDL2 
cholesterol was twice as high in active women than it was in 
inactive women in a study performed by Hartung et al. In the 
same study, HDL3 cholesterol values were similar for the two 
groups. This data suggests that exercise has no effect on HDL3 
levels and therefore increases only HDL2 levels (23).
Numerous epidemiologic studies have supported the fact that 
regular vigorous exercise decreases the morbidity and mortality 
from CHD (26). There are few studies finding no benefit from 
long-term exercise and none that report that exercise aggravates 
CHD or hastens the development of clinical disease (26) . It has 
also been suggested that the antiatherogenic effect that is
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elicited by exercise is due to the alterations in the lipid 
profile, specifically increases in HDL2 . Unfortunately, the 
amount of exercise necessary to elicit these increases in HDL2 is 
unclear.
Improvement in cardiovascular fitness is directly related to 
the intensity, duration, and frequency of exercise. An exercise 
intensity of 50 - 85% maximal VO2 , a duration of 15 - 60 minutes 
of continuous activity, and a frequency of 3 - 5 days per week 
have been recommended for developing and maintaining fitness in 
adults (31).
Although the literature defines a threshold necessary to 
produce cardiovascular fitness, the literature does not provide 
consensus with regard to the amount or intensity of aerobic 
exercise that is necessary to cause favorable changes in HDL2 •
It is unclear whether the increases in HDL2 require only a 
minimal training stimulus or whether greater amounts of exercise 
will elicit greater benefits.
Hypothesis
High intensity exercise training will improve the HDL 
profile significantly more than will low intensity exercise 
training.
CHAPTER THREE 
METHODOLOGY
RESEARCH DESIGN
This was a longitudinal, prospective, and randomized, 
experimental study of the effect of training intensity on changes 
in plasma HDL2 • The independent variable of this study was 
exercise intensity. The dependent variable was gain score of 
HDL2 . Peak oxygen uptake was measured before and after training 
to determine if a general training adaptation had been elicited.
SUBJECTS
Female employees of a 529 bed, teaching hospital and their 
acquaintances were recruited for this study. Subjects were 
included after meeting the following criteria:
1) No contraindications to exercise testing (Appendix I).
2) Taking no medications known to alter lipid metabolism.
3) Taking no antihypertensive medications or medications 
known to blunt the heart rate response to exercise.
4) Non-exerciser for previous six months.
5) Normal resting and exercise 12 lead electrocardiogram.
6 ) Normal resting and exercise blood pressure.
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7) Agreement to exercise within the guidelines of the 
study.
8) Between 20 and 50 years old, premenopausal.
Subjects were excluded from the study according to the
absolute and relative contraindications for exercise testing 
adapted from the American College of Sports Medicine, Guidelines 
for Exercise Testing and Prescription. Fourth Edition (Appendix
II) .
APPARATUS AND INSTRUMENTATION
Health history form. An instrument to obtain a health history 
was developed (Appendix I). Items of interest were age, gender, 
physician, current medications, past history or family history of 
cardiovascular disease, pulmonary disease and risk factors for 
coronary heart disease.
Consent form. A form was developed to provide the subject with 
an informed consent regarding the protocol and the risks of 
exercise testing. (Appendix III). Subjects were informed of 
Michigan law requiring blood to be tested for Hepatitis B and HIV 
in the instance where a health care worker has an accidental 
exposure to a blood sample. Confidentiality was assured. The 
consent form was read aloud to each subject to ensure 
dissemination of information. The form was signed and witnessed.
Indications for stopping an exercise test. Indications for
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stopping an exercise test were in accordance with those set forth 
by The American College of Sports Medicine, Guidelines for 
Exercise Testing and Prescription. Fourth Edition (Appendix IV). 
These guidelines were used in the event a subject needed to 
terminate the test prior to fatigue.
Personal exercise log. A form was developed for subjects to 
document their heart rate response to exercise, their distance 
walked, and the time it took to cover that distance. Subjects 
were instructed to complete the form following each exercise 
session. Logs were collected biweekly and reviewed for 
compliance measures.
Blood sampling equipment, A 21-gauge needle was inserted into 
the median cubital vein for the purpose of drawing a blood 
sample. Ten milliliters of blood were collected into ten 
milliliter glass vacutainers. The samples were centrifuged and 
stored at -70 degrees Celsius.
Exercise testing equipment. A Marquette Case 12 treadmill and 
ECG system was utilized for each of the exercise evaluations. A 
MedGraphics Systems 2001 metabolic cart was used to analyze 
oxygen consumption during each exercise evaluation.
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PROCEDURE
General information regarding a walking health promotion 
program was distributed throughout the hospital. Women who were 
interested in participating were informed that the walking 
program was a part of an experimental study. At this point they 
had the choice of participating in the study or participating in 
the walking program only. The women who chose to be a subject in 
the study scheduled an initial interview, blood draw, and maximal 
graded exercise test (GXT) that was to occur no longer than 24 
hours following the blood draw.
The initial interview consisted of the investigator reading 
the informed consent form (Appendix III) to the subject, 
answering questions related to the consent, and obtaining a 
signature from the subject indicating informed consent was given 
by the subject to participate in all the outlined aspects of the 
study. The investigator then read the health history form 
(Appendix I) to the subject and obtained the information recorded 
on the form. Participants were randomly assigned to one of two 
exercise intensity groups. The control group was the low 
intensity (L.I.) exercise group and the experimental group was 
the high intensity (H.I.) exercise group.
Subjects were instructed to abstain from food, beverages 
with the exception of water, and exercise for 12-14 hours prior 
to their scheduled blood draw. Subjects reported to the hospital 
laboratory where their blood was drawn by a certified 
phlebotomist according to the previously outlined procedure and
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stored for future analysis.
Within 24 hours of the initial blood draw, subjects reported 
to the exercise testing laboratory where they engaged in a 
maximal exercise test (Tl). A 12-lead ECG monitoring system was 
applied and the subjects were instructed to lie flat for 5 
minutes. Resting heart rates, systolic and diastolic blood 
pressures and ECG tracings were obtained in the supine, sitting 
and standing positions. The metabolic cart was calibrated and 
resting values of metabolic data were recorded.
Subjects performed the exercise test according to the Bruce 
Protocol (Appendix V) . Heart rates, 3 lead ECG's and metabolic 
data were continuously monitored. Blood pressures and 12 lead 
ECG tracings were recorded every 3 minutes and at peak exercise. 
The exercise test was terminated according to the indications for 
stopping an exercise test (Appendix IV). Subjects remained on 
the monitoring equipment until their heart rate and blood 
pressure had returned to baseline.
Individual training heart rates (THR) were calculated based 
on the heart rate reserve (HRR) formula:
THR = (PHR - RHR) X 60% + RHR 
or
THR = (PHR - RHR) X 80% + RHR
PHR = Peak Heart Rate 
RHR = Resting Heart Rate
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Subjects assigned to the L.I. group exercised at their training 
heart rates calculated at 60% HRR. Subjects assigned to the H.I. 
group exercised at their training heart rates calculated at 80% 
HRR.
Subjects were instructed to walk 2 miles 3 times per week at 
their prescribed target heart rate. A warm up period of 5 
minutes, in which the subject gradually raised her heart rate to 
the prescribed level, was not to be included in the 2 miles. 
Exercise logs (Appendix VI) were distributed with instructions 
for their use. Compliance was measured using the logs. Accepted 
minimal compliance was 80%. The subjects were required to walk 
at least two times per week but no more than four times per week 
to be considered compliant. This corresponds to 29-43 total 
exercise sessions.
Subjects were taught to take their radial pulse. Training 
intensity was monitored by the subject palpating the radial pulse 
before exercise and frequently during each exercise session to 
ensure maintenance of the target heart rate. The walking pace 
was adjusted accordingly.
Subjects followed the prescribed regimen for 11 weeks. A 
post-training blood draw and GXT (T2) was scheduled for the 12th 
week. Procedures and protocols for these tests were identical to 
the initial test prior to training.
Blood samples were kept frozen until all samples had been 
collected and could be analyzed with the same equipment on the 
same day. Total HDL was fractionated into HDL2 and HDL3 using a
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procedure modified from Warnick and Abers published procedure for 
measuring total HDL cholesterol (24) . This method required two 
precipitations with dextran sulfate solution containing different 
amounts of magnesium chloride. Total HDL cholesterol was 
measured after serum LDL and VLDL were selectively precipitated 
by magnesium-dextran sulfate and removed by centrifugation. The 
supernatant contained the cholesterol associated with the soluble 
HDL fraction which was precipitated again with a high 
concentration of magnesium chloride-dextran solution to 
precipitate HDL2 . The final supernatant was analyzed for HDLj 
and the difference in the total HDL cholesterol and the HDL3 was 
recorded as it was a close approximation of the HDL2 
concentration.
STATISTICS.
All statistics were analyzed using the ICS software package 
on IBM compatible computers. The data was statistically compared 
using Student's dependent and independent t-tests. Dependent t- 
t-tests were used when comparing pre and post training values 
within a group and when comparing initial differences between 
groups. Independent t-tests were used when comparing the 
differences in pre to post training values among groups.
Necessary and sufficient sample size was computed to be 19 
subjects per group at a power of .80. In all cases, an alpha 
level of less than .05 indicated a statistically significant 
difference (p<.05).
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CHAPTER FOUR 
RESULTS
Characteristics of Subjects
Forty-four subjects were included in this study. One woman 
did not report for her initial evaluation. Three women did not 
meet the criteria for selection. Of the three who did not meet 
the criteria, two had abnormal exercise ECG's and one was taking 
an antihypertensive medication.
Forty remaining candidates participated in the study.
Twenty subjects were randomly assigned to the control group,
L.I., and twenty subjects were randomly assigned to the 
experimental group, H.I. Thirteen subjects did not adhere to the 
regimen. Data from these subjects were not included in the 
analysis. Two of the subjects' post test results were not 
accurate due to equipment failure.
Twenty-five subjects met the criteria and completed 
participation in the study. Twelve individuals exercised at 60% 
of their heart rate reserve (L.I.), and thirteen individuals 
exercised at 80% of their heart rate reserve (H.I).
Descriptive characteristics between groups were
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statistically similar at the beginning of the study. Table 1 
summarizes physical and physiologic characteristics for L.I. and
H.I. groups.
Table 1
Demographic Description of Subjects
L. I. H.I.
Characteristic X SD X SD Significance
Age (yrs) 40.5 8.1 37.8 7.8 NS
Height (cm) 162.1 8 .1 165.5 3.7 NS
Weight (kg) 76.1 19.4 63.7 6.8 NS
RHR (b/min) 79.5 9.1 78.4 9.7 NS
RSBP (mmHg) 122.7 7.9 120.2 16.8 NS
RDBP (mmHg) 78.7 6.1 76.7 7.6
1
NS
RHR = Resting Heart Rate
RSBP = Resting Systolic Blood Pressure
RDBP = Resting Diastolic Blood Pressure
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The exercise response before training is summarized in 
table 2. Both heart rate and systolic blood pressure increased 
significantly from rest to peak exercise (p<.05). No significant 
difference in heart rate, systolic blood pressure or diastolic 
blood pressure response was observed between groups.
Table 2
Exercise Response Before Training
L. I. H. I.
Rest Peak Rest Peak
X SD X SD X SD X SD
HR (b/min) 79.5 9.1 180.4 14.4 78.4 9.7 177.8 10.7
SBP (mmHg) 122.7 7.9 153.6 13.3 120.2 16.8 146.0 15.1
DBP (mmHg) 78.7 6.1 80.7 12.3 76.7 7.6 79.2 7.2
HR = Heart Rate
SBP = Systolic Blood Pressure
DBP = Diastolic Blood Pressure
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Both L.I. and H.I. groups increased their exercise test 
duration and peak VO2 on the post training GXT (p<.005). Table 3 
summarizes these results.
Table 3
Exercise Response to Training
L. I. H. I.
Tl T2 Tl T2
X SD X SD X SD X SD
PHR (b/min) 180.4 14.4 178.6 14.3 177.8 10.6 181.8 11.8
Time (min) 7:59 1:41 9:13* 1:57 8:32 2:00 9:45* 2; 19
PVO2 (ml/kg/min) 29.0 5.0 31.9* 5.4 30.7 5.2 33.5* 6.3
PHR = Peak Heart Rate
PVO2 = Peak Oxygen Consumption
* indicates significantly increased when compared to Tl.
These improvements in exercise capacity were similar for the 
L.I. and H.I. groups.
Oxygen consumption at THR was lower in the L.I. group as 
compared to the H.I. group at Tl and T2. These values were 
approximately 17.6 ml/kg/min and 24.7 ml/kg/min at Tl, and 18.1 
ml/kg/min and 23.1 ml/kg/min at T2 respectively.
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Lipoprotein data are presented in table 4. Both the L.I. 
and the H.I. groups showed increases in all components of the HDL 
profile (p<.05). There were no significant differences in HDL 
profile gain scores between groups (table 5).
Table 4
HDL Profile Changes with Exercise Training
L.I. H.I.
Pre Post Pre Post
X SD X SD X SD X SD
HDL (mg/dl) 32.3 8.5 40.3 10.6 31.6 6.2 38.2 12.0
HDL2 (mg/dl) 14.2 5.7 18.5 6.9 13.0 6.2 19.6 8.9
HDL] (mg/dl) 18.2 5.4 21.7 6.7 17.8 4.9 18.6 5.6
Table 5
Gain Score Difference of HDL Profile Between Groups
L. I. H. I.
X SD X SD Significance
HDL (mg/dl) 7.9 9.9 6.6 10.3 NS
HDL2 (mg/dl) 4.4 6.3 6.5 8.3 NS
HDL] (mg/dl) 3.6 7.7 .81 4.5 NS
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CHAPTER FIVE 
DISCUSSION
Numerous epidemiologic studies have suggested that HDL has 
an inverse relationship with the risk of coronary heart disease 
(2,12). Furthermore, plasma HDL concentrations have been shown 
to be the strongest predictor of the development and progression 
of CRD (4,16). Recently, investigators have suggested that the 
ability of plasma HDL concentrations to predict CHD may be 
strengthened by analyzing the individual components of total HDL 
(4,16,25).
Initiation of an exercise training program is generally a 
part of first step intervention for treatment of hyperlipidemia. 
Exercise training is known to increase plasma concentrations of 
HDL, favorably altering the lipid profile. Recently, it has been 
suggested that exercise may be responsible for altering only the 
HDL2 component of total HDL (23). This finding may further 
clarify the benefit of exercise training because the 
antiatherogenic properties of HDL may be specific to the 
subfraction HDLg.
The initial HDL profile values in the sample group were less
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than what might have been expected. The HDL level of the L.I. 
group was 32.3 mg/dl with a standard deviation of 8.5 mg/dl. The 
HDL level of the H.I. group was 31.6 mg/dl with a standard 
deviation of 6.2 mg/dl. The American Heart Association (AHA) and 
the NCEP defines an HDL level of < 35 mg/dl indicative of 
increased risk for CHD (27,32), whereas an HDL level of 60 mg/dl 
or greater is considered a negative risk factor (27). It was 
stated that the women in this study had been non-exercisers for 
the previous six months. This may have contributed to low 
initial HDL levels.
Total HDL levels increased 24% and 21% in the L.I. and the
H.I. groups respectively. HDL2 levels increased 31% and 50% 
respectively, and HDL3 levels increased 20% and 4% respectively. 
These numbers may suggest clinical importance related to a 
decreased risk for CHD.
Exercise thresholds necessary to produce cardiovascular 
fitness have been well documented in the literature. The 
American College of Sports Medicine (ACSM) makes recommendations 
for the quantity and quality of exercise necessary to enhance 
health and fitness. An exercise frequency of three to five days 
per week at an intensity of 40-85% maximal VO2 for 15 to 60 
minutes are the guidelines established (31). Intensity of 
exercise may be calculated according to a variety of 
calculations. It has been determined that the HKR method for 
calculating training heart rates corresponds to approximately the 
same percentage as methods calculated using maximal VO2 (31).
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Not so clearly documented however, is the exercise threshold 
necessary to produce favorable alterations in the HDL profile, 
and even more specifically, favorable alterations in HDL2 .
Results of the present study indicted that training at an 
intensity of between 60% and 80% HRR provided a sufficient 
stimulus for eliciting increases in HDL and HDL2 • However, 
training at 80% HRR elicited no greater benefit than did training 
at 60% HRR.
The H.I. training group gained no greater training 
adaptation than did the L.I. training group. A reason for this 
similarity may have been that training intensities of 60 and 80% 
HRR were too similar to elicit a varied response. Surprising was 
the fact that the H.I, group’s RHR increased from pre training to 
post training. This may have been the result of not allowing an 
adequate rest period for the heart rate to truly reach resting 
values prior to collecting data.
Metabolic intensity of exercise, as measured by oxygen 
consumption, did not appear to change in either group as a result 
of exercise training. This observation may be explained by 
walking not being an adequate stimulus to elicit significant 
changes in cardiovascular function. This is does not assume 
however, that walking will not elicit significant health 
benefits. This observation also indicates that there was a clear 
differentiation in exercise intensities between L.I. and H.I, 
throughout the 1 1-week training period.
Evidence cited by Hartung et al stated that exercise has no
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effect on HDL3 levels (23). HDL3 increased in both the L.I. and 
the H.I. groups in this study. These increases may have been due 
to variables not controlled in this study. One such variable may 
have been increased alcohol consumption (13). Robinson et al 
hypothesizes that HDL3 may be a precursor to HDL2 formation. If 
this is found to be true, the noted increases may be clinically 
important. Based on the cited results of this study, the 
hypothesis that high intensity training improves the HDL profile 
more than low intensity training was rejected.
Although subjects were encouraged not to alter their dietary 
habits or alcohol and cigarette use during the course of the 
study, lifestyle-related risk factors were not controlled since 
HDL2 concentrations are not affected by factors other than 
exercise. The observed increases in total HDL were primarily the 
result of increases in HDL2 .
Other studies that have attempted to define a training 
stimulus necessary to produce alterations in the HDL profile have 
not controlled the volume of exercise (3). Investigators have 
prescribed the duration of exercise to be a period of time rather 
than a distance. Consequently, H.I. groups would have 
accumulated a larger volume of exercise as compared to the L.I. 
groups. In this study, all subjects, regardless of training 
group, walked for 2 miles thereby keeping the volume of exercise 
relatively constant. The results may have suggested that the 
alteration of the HDL profile is training volume dependent.
Although the volume of exercise was relatively constant
25
between groups, the initial difference (not statistically 
significant) in weight between groups resulted in the L.I. group 
expending approximately 2 , 0 0 0 more calories throughout the total 
12 week period. It appeared that the H.I. group expended less 
calories but had greater improvements in HDL2 than did the L.I. 
group. This may be explained by baseline differences in HDL2 and 
HDL3 .
It was also important in this study to analyze all blood 
samples the same day. Samples were kept frozen at -70 degrees 
Celsius which has been shown not to alter the composition or 
results of the analysis (33) . Mechanical variability was 
decreased due to this procedure.
Although attrition was high in this study, a significant 
improvement in the HDL profile was observed. Therefore, these 
results can be generalized to similar populations. Moreover, the 
observation of a significant change in the HDL profile suggests 
that the probability of a type II error was low.
Limitations of this study include an estimation rather than 
direct measurement of HDL2 , limited assessment of compliance, 
lack of control of leisure activity, and a small sample size. 
Based on these limitations, the results of this study can only be 
generalized to this group of subjects.
RECOMMENDATIONS
Outcomes of this study indicate a need for future research 
to be done on the effect of high intensity exercise training 
versus low intensity exercise training on fractionated plasma
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high-density lipoprotein cholesterol. Studies should be done to 
include the following recommendations:
1 . a controlled exercise setting in which attendance, 
distance walked, and heart rate could be monitored
2. develop THR based on VO2 rather than HRR
3. frequently reasses VO2 at THR and adjust to assure 
training intensity is being maintained
4. minimize leisure activity that is beyond the 
recommendations of the study
5. lengthen duration of exercise training period
6 . recruit larger sample size to allow for attrition
due to lengthened exercise training period
CONCLUSION
The results of the present study and those reported in the 
literature suggest that the favorable alterations in HDL profile 
may occur at the lower range of intensities required to produce 
improvements in fitness. These data indicated that training at 
60% HRR will produce alterations in the HDL profile that are 
similar to training at 80% HRR. In view of these findings, 
exercise prescriptions focused on improving the HDL profile may 
be calculated at the lower end of the range of intensities 
previously identified to produce cardiovascular fitness. This 
may be important because lower intensity exercise does not carry 
the orthopaedic risk that higher intensity exercise does and it 
may be more enjoyable for the exerciser, thereby improving long 
term adherence.
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APPENDICES
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Name;
Age:
Physician:
Medications :
Appendix I 
Health History
Birthdate:
Date__
Gender :
Past History
I. CV System 
MI:
PTCA:
Rapid heart rate:
HTN:_______
Ankle swelling:__
SOB with exercise:
Congenital heart disease:
CABG:
Palpitations:
Murmur:______
CVA:_______
PVD:
Angina at rest or with exercise:
II. Pulmonary System
Pulmonary disease:_______________
III. Risk Factors
Abnormal blood lipids:______
Diabetes:_______
Family history:_______
Smoking;_______
Exercise:
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IV. other
Recent illness/hospitalization;
Orthopaedic problems:
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Appendix II 
Contraindications to Exercise Testing 
Absolute Contraindications
1. A recent significant change in the resting ECG 
suggesting infarction or other acute cardiac event
2. Recent complicated myocardial infarction
3. Unstable angina
4. Uncontrolled ventricular dysrhythmia
5. Uncontrolled atrial dysrhythmia that compromises cardiac 
function
6 . Third degree AV block
7. Acute congestive heart failure
8 . Severe aortic stenosis
9. Suspected or known dissecting aneurysm
10. Active or suspected myocarditis or pericarditis
11. Thrombophlebitis or intracardiac thrombi
12. Recent systemic or pulmonary embolus
13. Acute infection
14. Significant emotional distress (psychosis)
Relative Contraindications
1. Resting diastolic blood pressure > 120 mmHg or resting 
systolic blood pressure > 200mmHg
2. Moderate valvular heart disease
3. Known electrolyte abnormalities (hypokalemia, 
hypomagnesemia)
4. Fixed rate pacemaker
5. Frequent or complex ventricular ectopy
6 . Ventricular aneurysm
7. Cardiomyopathy, including hypertrophic cardiomyopathy
8 . Uncontrolled metabolic disease (diabetes, thyrotoxicosis, or 
myxedema)
9. Chronic infectious disease (mononucleosis, hepatitis, AIDS)
10. Neuromuscular, musculoskeletal, or rheumatoid disorders that 
are exacerbated by exercise
11. Advanced or complicated pregnancy
ACSM - Guidelines for exercise testing and prescription. Fourth
Edition
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Appendiz III 
Consent Form
The effect of high intensity exercise training versus low inten­
sity exercise training on high density lipoprotein subfraction 2 
(HDL2 ) cholesterol.
It is known that exercise training favorably modifies some 
risk factors for coronary artery disease (CAD). Among these risk 
factors is an elevated serum cholesterol, primarily a low HDL 
component and a high low density lipoprotein (LDL) component. 
Exercise training has been shown to increase HDL cholesterol 
believed to be the protector against CAD. It is also not known 
how hard one must exercise before these increases begin to occur. 
Therefore, your participation in the study may help to determine 
how hard one must exercise to improve the protective effects.
As a participant you will be asked to complete two exercise 
evaluations. Both evaluations will require ten electrodes be 
placed on your chest to permit recording of your heart rate and 
rhythm. Oxygen consumption will be measured by breathing into a 
mouthpiece. During the evaluation the treadmill will increase in 
speed and elevation every 3 minutes. Results of this test will 
be used in determining an exercise prescription. Three fasting 
blood samples will be drawn during this study. Each sample will 
require 10 milliliters of blood be drawn.
The associated risks of the exercise evaluations re those 
that apply to exercise participation in general. These risks are 
muscle soreness, muscular straining, sprains, chest pain, nausea, 
dizziness, heart attacks and sudden death. The potential risks 
of drawing blood include a bruise at the site of the vein punc­
ture, inflammation of the vein and infection. Costs associated 
with any injury will not be covered by the investigator or by 
Butterworth Hospital. You have the right to refuse or stop 
participating at any time during the procedure without penalty or 
jeopardy of the quality or quantity of treatment you are now 
receiving or may receive in the future at Butterworth Hospital.
Information obtained from this study will be held in strict 
confidence and be reported only in research forums. Data will 
not be identified by name in any presentation.
You will be one of 58 people participating in this study.
The benefits of your participation may include a contribution to 
the overall understanding of the role exercise plays in the 
reduction of risk for coronary artery disease and may further 
define optimal training intensities.
Questions regarding your rights as a subject can be answered
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by calling Linda Pool at the Butterworth Institutional Review 
Board at (616) 774-1291/1299. Questions related to other aspects 
of your participation can be answered by calling Terri Spate at 
(616) 774-1320.
In accordance with Michigan law your blood will be tested 
for Hepatitis B and HIV (AIDS virus) in those instances where a 
health care worker has an accidental exposure to your blood.
These results will be noted on your chart due to an employee 
occupational exposure. You will be notified of any positive 
results.
I have read the above statements and am aware of the 
risks involved with participation and my rights as a subject. I 
agree to participation in this research study.
Sub]ect Date
Investigator Date
Witness Date
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Appendix IV
Indications for Stopping an Exercise Test
1. Progressive angina (stop at 3+ level or earlier on a scale 
of 1+ to 4+)
2. Ventricular tachycardia
3. Any significant drop (20mmHg) of systolic blood pressure or a
failure of the systolic blood pressure to rise with an 
increase in exercise load
4. Lightheadedness, confusion, ataxia, pallor, cyanosis, nausea, 
or signs of severe peripheral circulatory insufficiency
5. Early onset of deep (>4mm) horizontal or downsloping ST 
depression or elevation
6 . Onset of second or third degree AV block
7. Increasing ventricular ectopy, multiform PVCs, or R on T PVCs
8 . Excessive rise in blood pressure; systolic pressure >
250mmHg; diastolic pressure > 1 2 0  mmhg
9. Chronotropic impairment; increase in heart rate that is < 25 
beats/min below age predicted normal value (in the absence of 
beta blockade)
10. Sustained supraventricular tachycardia
11. Exercise induced left bundle branch block
12. Subject requests to stop
13. Failure of the monitoring system
ACSM- Guidelines for exercise testing and prescription. Fourth
Edition.
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Appendix V 
Bruce Protocol
stage MPH Grade Min.
MB']
Men
? Requiremer 
Women
It
Cardiac
1 3.2 3.1 3.6
I 1.7 10% 2 4.0 3.9 4.3
3 4.9 4.7 4.9
4 5.7 5.4 5.6
II 2.5 12% 5 6 .6 6.2 6.2
6 7.4 7.0 7.0
7 8.3 8.0 7.6
III 3.4 14% 8 9.1 8.6 8.3
9 10.0 9.4 9.0
10 10.7 10.1 9.7
IV 4.2 16% 11 11.6 10.9 10.4
12 12.5 11.7 11.0
13 13.3 12.5 11.7
V 5.0 18% 14 14.1 13.2 12.3
15 15.0 14.1 13.0
ACSM - Guidelines for exercise testing and prescription.
Edition.
Fourth
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Appendix VI
Personal Exercise Log
Date
M
T
W
T
F
S
S
M
T
W
T
F
S
S
Pre
Pulse 
Dur Post Distance Time Comments
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